In the current study, the results showed that ATPR inhibited the expression of E2A, thereby reducing the downstream target gene c‐Myc, activating the P53 pathway and inducing AML cell differentiation and cycle arrest. This evidence concerns the gene MYC and acute myeloid leukemia.